Unexpected inverse correlation between Native American ancestry and Asian American variants of HPV16 in admixed Colombian cervical cancer cases

Infection, Genetics and Evolution

Volumn 28, Issue , 2014, Pages 339-348

  Lopera, Esteban A ^a   Baena, Armando ^a   Florez, Victor ^a   Montiel, Jehidys ^a   Duque, Constanza ^a,b   Ramirez, Tatiana ^a   Borrero, Mauricio ^a,c   Cordoba, Carlos M ^a   Rojas, Fredy ^c   Pareja, Rene ^c   Bedoya, Astrid M ^a   Bedoya, Gabriel ^a   Sanchez, Gloria I ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD COOPERATIVA DE COLOMBIA   (Colombia)

^c Section of Neuro oncology   (Colombia)

Author keywords

Admixture; Cervical cancer; Colombia; Genetic ancestry; HPV variants; Human papillomavirus 16

Indexed keywords

PROTEIN E6;

ADULT; AGE; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CANCER RISK; COEVOLUTION; COLOMBIA; COLOMBIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ETHNICITY; EUROPEAN; FEMALE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYBRIDIZATION; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; VIRUS GENE; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CLASSIFICATION; GENETICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84918512294     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.10.014     Document Type: Article

References (58)

1. Baay M.F., Quint W.G., Koudstaal J., Hollema H., Duk J.M., Burger M.P., Stolz E., Herbrink P. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 1996, 34:745-747.
2. Bedoya G., Montoya P., García J., Soto I., Bourgeois S., Carvajal L., Labuda D., Alvarez V., Ospina J., Hedrick P.W., Ruiz-Linares A. Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7234-7239.
3. Bernard H.U. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J. Clin. Virol. 2005, 32(Suppl. 1):S1-S6.
4. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl Cancer Inst. 2001, 93:1325-1330.
5. Bontkes H.J., de Gruijl T.D., van den Muysenberg A.J., Verheijen R.H., Stukart M.J., Meijer C.J., Scheper R.J., Stacey S.N., Duggan-Keen M.F., Stern P.L., Man S., Borysiewicz L.K., Walboomers J.M. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. Int. J. Cancer 2000, 88:92-98.
6. Brake T., Lambert P.F. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2490-2495.
7. Bravo I.G., de Sanjosé S., Gottschling M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol. 2010, 18:432-438.
8. Bravo M.M. Variantes moleculares en el gen L1 del virus del papiloma humano tipo 16, y regiones de la proteína L1 probablemente involucradas en la interacción virus-célula epitelial. IATREA 2004, 17:314.
9. Burk R.D., Harari A., Chen Z. Human papillomavirus genome variants. Virology 2013, 445:232-243.
10. Calleja-Macias I.E., Kalantari M., Huh J., Ortiz-Lopez R., Rojas-Martinez A., Gonzalez-Guerrero J.F., Williamson A.L., Hagmar B., Wiley D.J., Villarreal L., Bernard H.U., Barrera-Saldana H.A. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004, 319:315-323.
11. Chan S.Y., Ho L., Ong C.K., Chow V., Drescher B., Durst M., ter Meulen J., Villa L., Luande J., Mgaya H.N., et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 1992, 66:2057-2066.
12. Cornet I., Gheit T., Clifford G.M., Combes J.D., Dalstein V., Franceschi S., Tommasino M., Clavel C. Human papillomavirus type 16 E6 variants in France and risk of viral persistence. Infect Agent Cancer 2013, 8:4.
13. Cornet I., Gheit T., Franceschi S., Vignat J., Burk R.D., Sylla B.S., Tommasino M., Clifford G.M. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 2012, 86:6855-6861. I.H.V.S. Group.
14. Cornet I., Gheit T., Iannacone M.R., Vignat J., Sylla B.S., Del Mistro A., Franceschi S., Tommasino M., Clifford G.M. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 2013, 108:240-244.
15. de Araujo Souza P.S., Maciag P.C., Ribeiro K.B., Petzl-Erler M.L., Franco E.L., Villa L.L. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 2008, 8:246.
16. de Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., Jordanova E.S., Kolkman-Uljee S., Fleuren G.J. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol. Oncol. 2004, 94:488-494.
17. de Roda Husman A.M., Snijders P.J., Stel H.V., van den Brule A.J.C., Walboomers J.M.M. Processing of long-stored archival smears for human papillomavirus detection by the polymerase chain reaction. Br. J. Cancer 1995, 72:412-417.
18. del Refugio González-Losa M., Laviada Mier y Teran M.A., Puerto-Solís M., García-Carrancá A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J. Clin. Virol. 2004, 29:95-98.
19. Fejerman L., John E.M., Huntsman S., Beckman K., Choudhry S., Perez-Stable E., Burchard E.G., Ziv E. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res. 2008, 68:9723-9728.
20. Fejerman L., Romieu I., John E.M., Lazcano-Ponce E., Huntsman S., Beckman K.B., Pérez-Stable E.J., González Burchard E., Ziv E., Torres-Mejía G. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1074-1082.
21. Ferlay, Soerjomataram, Ervik, Dikshit, Eser, Mathers, Rebelo, Parkin, Forman, Bray, 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon/Geneva, Lyon, France.
22. Florez J.C., Price A.L., Campbell D., Riba L., Parra M.V., Yu F., Duque C., Saxena R., Gallego N., Tello-Ruiz M., Franco L., Rodríguez-Torres M., Villegas A., Bedoya G., Aguilar-Salinas C.A., Tusié-Luna M.T., Ruiz-Linares A., Reich D. Strong association of socioeconomic status with genetic ancestry in Latinos: implications for admixture studies of type 2 diabetes. Diabetologia 2009, 52:1528-1536.
23. Franco E., Villa L., Sobrinho J., Prado J., Rosseau M., Desy M., Rohan T. Epidemiology of the acquisition and clearance of cervical human papillomavirus infection en women from a high-risk area for cervical cancer. J. Infect. Dis. 1999, 180:1415-1423.
24. Galanter J.M., Fernandez-Lopez J.C., Gignoux C.R., Barnholtz-Sloan J., Fernandez-Rozadilla C., Via M., Hidalgo-Miranda A., Contreras A.V., Figueroa L.U., Raska P., Jimenez-Sanchez G., Zolezzi I.S., Torres M., Ponte C.R., Ruiz Y., Salas A., Nguyen E., Eng C., Borjas L., Zabala W., Barreto G., González F.R., Ibarra A., Taboada P., Porras L., Moreno F., Bigham A., Gutierrez G., Brutsaert T., León-Velarde F., Moore L.G., Vargas E., Cruz M., Escobedo J., Rodriguez-Santana J., Rodriguez-Cintrón W., Chapela R., Ford J.G., Bustamante C., Seminara D., Shriver M., Ziv E., Burchard E.G., Haile R., Parra E., Carracedo A., Consortium L. Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas. PLoS Genet. 2012, 8:e1002554.
25. González Burchard E., Borrell L.N., Choudhry S., Naqvi M., Tsai H.J., Rodriguez-Santana J.R., Chapela R., Rogers S.D., Mei R., Rodriguez-Cintron W., Arena J.F., Kittles R., Perez-Stable E.J., Ziv E., Risch N. Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am. J. Public Health 2005, 95:2161-2168.
26. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M.C., Sherman M.E., Scarpidis U., Lin Q.Q., Terai M., Bromley R.L., Buetow K., Apple R.J., Burk R.D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl Cancer Inst. 2001, 93:315-318.
27. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle J.P., Kahn T., Kiviat N., Lancaster W., Mavromara-Nazos P., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 1993, 67:6413-6423.
28. Hoggart C.J., Parra E.J., Shriver M.D., Bonilla C., Kittles R.A., Clayton D.G., McKeigue P.M. Control of confounding of genetic associations in stratified populations. Am. J. Hum. Genet. 2003, 72:1492-1504.
29. Holmes E.C. Evolutionary history and phylogeography of human viruses. Annu. Rev. Microbiol. 2008, 62:307-328.
30. Junes-Gill K., Sichero L., Maciag P.C., Mello W., Noronha V., Villa L.L. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil. J. Med. Virol. 2008, 80:1639-1645.
31. Kubinak J.L., Ruff J.S., Cornwall D.H., Middlebrook E.A., Hasenkrug K.J., Potts W.K. Experimental viral evolution reveals major histocompatibility complex polymorphisms as the primary host factors controlling pathogen adaptation and virulence. Genes Immun. 2013, 14:365-372.
32. Lace M.J., Isacson C., Anson J.R., Lörincz A.T., Wilczynski S.P., Haugen T.H., Turek L.P. Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J. Virol. 2009, 83:7457-7466.
33. Luhn P., Walker J., Schiffman M., Zuna R.E., Dunn S.T., Gold M.A., Smith K., Mathews C., Allen R.A., Zhang R., Wang S., Wentzensen N. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol. Oncol. 2013, 128:265-270.
34. López-Revilla R., Pineda M.A., Ortiz-Valdez J., Sánchez-Garza M., Riego L. Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico. Infect. Agent Cancer 2009, 4:3.
35. Mahmud S.M., Robinson K., Richardson H., Tellier P.P., Ferenczy A.S., Roger M., Coutlee F., Franco E.L. HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal University students. J. Infect. Dis. 2007, 196:82-90.
36. Mayrand M., Coutleé F., Hankins C., Lapointe N., Forest P., de Ladurantaye M., R.M. Detection of human papillomavirus type 16 in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J. Clin. Microbiol. 2000, 38:3388-3393. The Canadian women's HIV study group.
37. Molano, M., Huertas, A., 2010. A method for detection and identification of hpv16 variants using primers and probes. In: Patentscope (Ed.), Patentscope.
38. Parra E.J., Marcini A., Akey J., Martinson J., Batzer M.A., Cooper R., Forrester T., Allison D.B., Deka R., Ferrell R.E., Shriver M.D. Estimating African American admixture proportions by use of population-specific alleles. Am. J. Hum. Genet. 1998, 63:1839-1851.
39. Pereira R., Phillips C., Pinto N., Santos C., dos Santos S.E., Amorim A., Carracedo Á., Gusmão L. Straightforward inference of ancestry and admixture proportions through ancestry-informative insertion deletion multiplexing. PLoS ONE 2012, 7:e29684.
40. Picconi M.A., Alonio L.V., Sichero L., Mbayed V., Villa L.L., Gronda J., Campos R., Teyssie A. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J. Med. Virol. 2003, 69:546-552.
41. Piñeros M., Gamboa O., Hernández-Suárez G., Pardo C., Bray F. Patterns and trends in cancer mortality in Colombia 1984-2008. Cancer Epidemiol. 2013, 37:233-239.
42. Pérez-Gallego L., Moreno-Bueno G., Sarrió D., Suárez A., Gamallo C., Palacios J. Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am. J. Clin. Pathol. 2001, 116:143-148.
43. Quintero K., Giraldo G.A., Uribe M.L., Baena A., Lopez C., Alvarez E., Sanchez G.I. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Br. J. Otorhinolaryngol. 2013, 79:375-381.
44. Rodríguez A.C., Schiffman M., Herrero R., Wacholder S., Hildesheim A., Castle P.E., Solomon D., Burk R. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl Cancer Inst. 2008, 100:513-517. P.E.G. Group.
45. Rojas W., Parra M.V., Campo O., Caro M.A., Lopera J.G., Arias W., Duque C., Naranjo A., García J., Vergara C., Lopera J., Hernandez E., Valencia A., Caicedo Y., Cuartas M., Gutiérrez J., López S., Ruiz-Linares A., Bedoya G. Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers. Am. J. Phys. Anthropol. 2010, 143:13-20.
46. Rosenberg N.A., Li L.M., Ward R., Pritchard J.K. Informativeness of genetic markers for inference of ancestry. Am. J. Hum. Genet. 2003, 73:1402-1422.
47. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
48. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 2007, 120:1763-1768.
49. Sichero L., Franco E.L., Villa L.L. Different P105 promoter activities among natural variants of human papillomavirus type 18. J. Infect. Dis. 2005, 191:739-742.
50. Sichero L., Trottier H., Ferreira S., Duarte-Franco E., Franco E.L., Villa L.L. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl Cancer Inst. 2007, 99:653-654. (author reply 654-655).
51. Suarez-Kurtz G. Pharmacogenetics in the Brazilian population. Front Pharmacol. 2010, 1:118.
52. Tornesello M.L., Duraturo M.L., Salatiello I., Buonaguro L., Losito S., Botti G., Stellato G., Greggi S., Piccoli R., Pilotti S., Stefanon B., De Palo G., Franceschi S., Buonaguro F.M. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J. Med. Virol. 2004, 74:117-126.
53. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 2002, 40:779-787.
54. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
55. Xi L.F., Kiviat N.B., Hildesheim A., Galloway D.A., Wheeler C.M., Ho J., Koutsky L.A. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl. Cancer Inst. 2006, 98:1045-1052.
56. Yaeger R., Avila-Bront A., Abdul K., Nolan P.C., Grann V.R., Birchette M.G., Choudhry S., Burchard E.G., Beckman K.B., Gorroochurn P., Ziv E., Consedine N.S., Joe A.K. Comparing genetic ancestry and self-described race in African Americans born in the United States and in Africa. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1329-1338.
57. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., Wheeler C.M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 1997, 71:2463-2472.
58. Zehbe I., Mytilineos J., Wikstrom I., Henriksen R., Edler L., Tommasino M. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum. Immunol. 2003, 64:538-542.